Home

Environmental Laboratory Services

General Information
About NRC
Contact Us
Directions to NRC
Employment
General Services
Testing Methods & Equipment
Safety Training
Quality Control & Assurance
Laboratory Certifications
Home Owners
Public Water Systems
Drinking Water Rules
Testing Packages
Sampling & Preservation
List of Contaminants
Waste Water Permit Holders
Waste Water Treatment
NPDES Permit Holders
Stormwater Discharges
Clean Water Act
Governmental Agencies
Industry and Environmental Consultants
Industry Compliance
Hazardous Waste Determination
TCLP & SPLP
PCB's In Schools
Custom Services
 
 

 

 

Drinking Water Rules
Stage 1 and Stage 2 Microbial Disinfectants and
Disinfection Byproducts (M-DBP) Rules

After the amendments to the SDWA in 1996, rules were developed to balance the risks between microbial pathogens and disinfection byproducts (DBPs). It is important to strengthen protection against microbial contaminants, especially Cryptosporidium, and at the same time, reduce potential health risks of DBPs.

Stage 1 DBP rule was developed to protect public health by limiting exposure to these disinfectant byproducts.

According to the EPA, toxicology studies have shown several DBPs to be carcinogenic in laboratory animals, while others appear to cause adverse reproductive or developmental effects in laboratory animals. Epidemiology studies have suggested an association between certain cancers, and exposure to chlorinated water. More than 200 million people consume water that has been disinfected.

At NRC we have streamlined our compliance testing to meet all regulations. Your sample will be handled in accordance with standard methods and we will help maintain your monitoring schedule.

For the EPA Quick Reference Guide to Stage I DBP Rule, visit:
http://www.epa.gov/safewater/mdbp/qrg_st1.pdf

Stage 1 Disinfectants and Disinfection Byproducts Rule

Disinfection Byproducts

Contaminant MCLG(mg/L) MCL
(mg/L)
Potential Health Effects from Ingestion of Water Sources of Contaminant in Drinking Water
Bromate zero 0.010 Increased risk of cancer Byproduct of drinking water disinfection
Chlorite 0.8 1.0 Anemia; infants & young children: nervous system effects Byproduct of drinking water disinfection
Haloacetic acids (HAA5) n/a 0.060 Increased risk of cancer Byproduct of drinking water disinfection
Total Trihalomethanes (TTHMs) none
---------
n/a
0.10
---------
0.080
Liver, kidney or central nervous system problems; increased risk of cancer Byproduct of drinking water disinfection

Disinfectants

Contaminant MCLG
(mg/L)
MCL
(mg/L)
Potential Health Effects from Ingestion of Water Sources of Contaminant in Drinking Water
Chloramines (as Cl2) MRDLG=4 MRDL=4.0 Eye/nose irritation; stomach discomfort, anemia Water additive used to control microbes
Chlorine (as Cl2) MRDLG=4 MRDL=4.0 Eye/nose irritation; stomach discomfort Water additive used to control microbes
Chlorine dioxide (as ClO2) MRDLG=0.8 MRDL=0.8 Anemia; infants & young children: nervous system effects Water additive used to control microbes

Stage 2 DBP Rule
This final rule builds incrementally upon the previous rule and targets systems with the greatest risk. Systems that deliver disinfected water are required to meet maximum contaminant levels as an average at each monitoring location. Each size system must follow a prescribed monitoring schedule. The EPA has projected that this rule will prevent approximately 280 bladder cancer cases per year. Of these cases, 26% are estimated to be fatal.

For additional information, see the EPA Quick reference guide for your system:

Schedule 1 systems http://www.epa.gov/OGWDW/disinfection/stage2/pdfs/qrg_stage_2_dbpr_qrg_sch1_final.pdf

Schedule 2 systems http://www.epa.gov/OGWDW/disinfection/stage2/pdfs/qrg_stage_2_dbpr_qrg_sch2_final.pdf

Schedule 3 systems http://www.epa.gov/OGWDW/disinfection/stage2/pdfs/qrg_stage_2_dbpr_qrg_sch3_final.pdf

Schedule 4 systems
http://www.epa.gov/OGWDW/disinfection/stage2/pdfs/qrg_stage_2_dbpr_qrg_sch4_final.pdf

Return to the Neilson Research Corporation Home page
Copyright © 2007 Neilson Research Corporation